Back to Journals » Drug, Healthcare and Patient Safety
Drug, Healthcare and Patient Safety
ISSN: 1179-1365
An international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery. The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological and post-marketing surveillance studies, risk management, health literacy and educational programs across all areas of healthcare delivery. Also, guidelines on data requirements to assure acceptable safety levels in license applications, and post marketing protocols on monitoring safety on managing associated morbidity and mortality are key topics. Adverse reaction case reports, animal and in vitro toxicity studies are also welcome. Balancing risk, effectiveness, patient satisfaction and quality of life and the development and testing of new interventions to optimize clinical outcomes in disease management are major areas of interest for the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (287)
- Volume 16, 2024 (9)
- Volume 15, 2023 (16)
- Volume 14, 2022 (19)
- Volume 13, 2021 (25)
- Volume 12, 2020 (35)
- Volume 11, 2019 (15)
- Volume 10, 2018 (12)
- Volume 9, 2017 (11)
- Volume 8, 2016 (13)
- Volume 7, 2015 (20)
- Volume 6, 2014 (22)
- Volume 5, 2013 (23)
- Volume 4, 2012 (18)
- Volume 3, 2011 (15)
- Volume 2, 2010 (25)
- Volume 1, 2009 (9)
Latest articles:
- 5 records -
Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors
Chiumia FK, Chimimba F, Nyirongo HM, Kampira EL, Muula AS, Khuluza F
Drug, Healthcare and Patient Safety 2024, 16:89-101
Published Date: 23 July 2024
Medication-Related Hospital Admission Among Patients Admitted to the Emergency Ward at the University of Gondar, North West Ethiopia: A Cross Sectional Study
Gebremariam SN, Sema FD, Jara AG, Mekonnen GA
Drug, Healthcare and Patient Safety 2024, 16:75-88
Published Date: 17 July 2024
Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone
Thomas F, Abiri OT, Kallon JM, Kangbai DM, Conteh TA, Conteh SM, Samuels EG, Awodele O
Drug, Healthcare and Patient Safety 2024, 16:61-73
Published Date: 19 June 2024
Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
Cassady SJ, Almario JAN, Ramani GV
Drug, Healthcare and Patient Safety 2024, 16:51-59
Published Date: 5 June 2024
Rapid Onset and Recovery Linezolid-Induced Thrombocytopenia: A Large-Sample, Single-Center Retrospective Cohort Study
AL Qamariat Z, Aljaffar AA, Alabdulaal ZS, Alnezir F, Al-Zawad WM, Alqattan M, Almahdi A
Drug, Healthcare and Patient Safety 2024, 16:43-49
Published Date: 21 May 2024